Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
A double-blind comparison of balsalazide, 6.75 g, and sulfasalazine, 3 g, as sole therapy in the management of ulcerative colitis.
Alimentary pharmacology & therapeutics·2002
Does adjuvant nutritional support diminish steroid dependency in Crohn disease?
Scandinavian journal of gastroenterology·2001
Low mortality in ulcerative colitis and Crohn's disease in three regional centers in England.
The American journal of gastroenterology·2001
The rise of Clostridium difficile: the effect of length of stay, patient age and antibiotic use.
The Journal of hospital infection·2000
Maintenance of remission of ulcerative colitis: a comparison between balsalazide 3 g daily and mesalazine 1.2 g daily over 12 months. ABACUS Investigator group.
Alimentary pharmacology & therapeutics·1999
Host-microbiome interactions and enteric pathogen infections - from early-life to long-term impacts on gut-brain communication.
Journal of applied microbiology·2026
eGFR- and Potassium-Guided Stewardship of SGLT2 Inhibitors and Finerenone in Albuminuric Chronic Kidney Disease Associated with Type 2 Diabetes.
Diabetes, metabolic syndrome and obesity : targets and therapy·2026
Fucoxanthin Ameliorates Diabetic Kidney Disease via Modulating the Gut Microbiota and Tryptophan-Kynurenine Metabolic Pathway.
Journal of immunology research·2026